Fluoropharma Medical

PINK:FPMI USA Biotechnology

Market Cap

$3.43K

Market Cap Rank

#46719 Global

#14525 in USA

Share Price

$0.00

Change (1 day)

+0.00%

52-Week Range

$0.00 - $0.00

All Time High

$0.37

Fluoropharma Medical - Asset Resilience Ratio

Latest as of March 2014: 16.82%

Fluoropharma Medical (FPMI) has an Asset Resilience Ratio of 16.82% as of March 2014. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

$176.41K

Cash + Short-term Investments

Total Assets

$1.05 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2013)

This chart shows how Fluoropharma Medical's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Fluoropharma Medical's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$176.41K	16.82%
Total Liquid Assets	$176.41K	16.82%

Asset Resilience Insights

Good Liquidity Position: Fluoropharma Medical maintains a healthy 16.82% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.